BE887941A - Produits nutritifs et leur procede d'administration. - Google Patents

Produits nutritifs et leur procede d'administration. Download PDF

Info

Publication number: BE887941A
Authority: BE; Belgium
Prior art keywords: glycine; aqueous solution; product according; mammal; emi
Prior art date: 1980-03-14

Application number

BE0/204118A

Other languages

English (en)

French (fr)

Original Assignee

Adibi Siamak A

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1980-03-14

Filing date

1981-03-13

Publication date

1981-07-01

1981-03-13 Application filed by Adibi Siamak A filed Critical Adibi Siamak A

1981-07-01 Publication of BE887941A publication Critical patent/BE887941A/fr

Links

235000016709 nutrition Nutrition 0.000 title claims description 13
238000000034 method Methods 0.000 title claims description 10
108010038807 Oligopeptides Proteins 0.000 claims description 36
102000015636 Oligopeptides Human genes 0.000 claims description 36
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 16
239000007864 aqueous solution Substances 0.000 claims description 15
108010016626 Dipeptides Proteins 0.000 claims description 13
241000124008 Mammalia Species 0.000 claims description 12
235000020776 essential amino acid Nutrition 0.000 claims description 9
239000003797 essential amino acid Substances 0.000 claims description 9
239000004471 Glycine Substances 0.000 claims description 8
230000000050 nutritive effect Effects 0.000 claims description 8
229920005862 polyol Polymers 0.000 claims description 8
150000003077 polyols Chemical class 0.000 claims description 8
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 6
125000000539 amino acid group Chemical group 0.000 claims description 6
239000008103 glucose Substances 0.000 claims description 6
238000010253 intravenous injection Methods 0.000 claims description 5
239000003925 fat Substances 0.000 claims description 4
235000015097 nutrients Nutrition 0.000 claims description 4
235000013343 vitamin Nutrition 0.000 claims description 4
239000011782 vitamin Substances 0.000 claims description 4
229940088594 vitamin Drugs 0.000 claims description 4
229930003231 vitamin Natural products 0.000 claims description 4
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 3
239000004473 Threonine Substances 0.000 claims description 3
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 3
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 3
229910052500 inorganic mineral Inorganic materials 0.000 claims description 3
239000011707 mineral Substances 0.000 claims description 3
-1 oligosacchariàes Substances 0.000 claims description 3
239000004474 valine Substances 0.000 claims description 3
AYORUWNJMKYNAD-JEDNCBNOSA-N 2-aminoacetic acid;(2s)-2-amino-4-methylpentanoic acid Chemical compound NCC(O)=O.CC(C)C[C@H](N)C(O)=O AYORUWNJMKYNAD-JEDNCBNOSA-N 0.000 claims description 2
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 2
TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
235000014633 carbohydrates Nutrition 0.000 claims description 2
239000003792 electrolyte Substances 0.000 claims description 2
HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 2
230000002093 peripheral effect Effects 0.000 claims description 2
239000000700 radioactive tracer Substances 0.000 claims description 2
210000003462 vein Anatomy 0.000 claims description 2
HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
239000000811 xylitol Substances 0.000 claims description 2
229960002675 xylitol Drugs 0.000 claims description 2
235000010447 xylitol Nutrition 0.000 claims description 2
BKKWZCSSYWYNDS-JEDNCBNOSA-N 2-aminoacetic acid;(2s)-2,6-diaminohexanoic acid Chemical compound NCC(O)=O.NCCCC[C@H](N)C(O)=O BKKWZCSSYWYNDS-JEDNCBNOSA-N 0.000 claims 1
QGTPORGEFWYTOC-MDTVQASCSA-N 2-aminoacetic acid;(2s)-2,6-diaminohexanoic acid Chemical compound NCC(O)=O.NCCCC[C@H](N)C(O)=O.NCCCC[C@H](N)C(O)=O QGTPORGEFWYTOC-MDTVQASCSA-N 0.000 claims 1
DGRZRONVAUBBJY-NAWJVIAPSA-N 2-aminoacetic acid;(2s)-2-amino-3-(1h-indol-3-yl)propanoic acid Chemical compound NCC(O)=O.C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1.C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 DGRZRONVAUBBJY-NAWJVIAPSA-N 0.000 claims 1
CQBYLZOLQTWVOB-QXGOIDDHSA-N 2-aminoacetic acid;(2s)-2-amino-3-phenylpropanoic acid Chemical compound NCC(O)=O.OC(=O)[C@@H](N)CC1=CC=CC=C1.OC(=O)[C@@H](N)CC1=CC=CC=C1 CQBYLZOLQTWVOB-QXGOIDDHSA-N 0.000 claims 1
DQSIXGDDUJJEQH-QRPNPIFTSA-N 2-aminoacetic acid;(2s)-2-amino-3-phenylpropanoic acid Chemical compound NCC(O)=O.OC(=O)[C@@H](N)CC1=CC=CC=C1 DQSIXGDDUJJEQH-QRPNPIFTSA-N 0.000 claims 1
FSSVRLXFJPQUTM-WCCKRBBISA-N 2-aminoacetic acid;(2s)-2-amino-4-methylsulfanylbutanoic acid Chemical compound NCC(O)=O.CSCC[C@H](N)C(O)=O FSSVRLXFJPQUTM-WCCKRBBISA-N 0.000 claims 1
IDFKSUXUURJYNF-SCGRZTRASA-N 2-aminoacetic acid;(2s)-2-amino-4-methylsulfanylbutanoic acid Chemical compound NCC(O)=O.CSCC[C@H](N)C(O)=O.CSCC[C@H](N)C(O)=O IDFKSUXUURJYNF-SCGRZTRASA-N 0.000 claims 1
XGKCWNGHLZXLTK-MUWMCQJSSA-N 2-aminoacetic acid;(2s,3r)-2-amino-3-hydroxybutanoic acid Chemical compound NCC(O)=O.C[C@@H](O)[C@H](N)C(O)=O XGKCWNGHLZXLTK-MUWMCQJSSA-N 0.000 claims 1
MNQVNFIVCSQNGY-FHAQVOQBSA-N 2-aminoacetic acid;(2s,3s)-2-amino-3-methylpentanoic acid Chemical compound NCC(O)=O.CC[C@H](C)[C@H](N)C(O)=O MNQVNFIVCSQNGY-FHAQVOQBSA-N 0.000 claims 1
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims 1
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims 1
150000001298 alcohols Chemical class 0.000 claims 1
229960000310 isoleucine Drugs 0.000 claims 1
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims 1
235000008935 nutritious Nutrition 0.000 claims 1
239000000600 sorbitol Substances 0.000 claims 1
239000000243 solution Substances 0.000 description 25
235000001014 amino acid Nutrition 0.000 description 22
150000001413 amino acids Chemical class 0.000 description 21
239000000203 mixture Substances 0.000 description 13
125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 7
235000018102 proteins Nutrition 0.000 description 6
102000004169 proteins and genes Human genes 0.000 description 6
108090000623 proteins and genes Proteins 0.000 description 6
241000282414 Homo sapiens Species 0.000 description 4
210000004027 cell Anatomy 0.000 description 4
230000000694 effects Effects 0.000 description 4
108090000765 processed proteins & peptides Proteins 0.000 description 4
230000002354 daily effect Effects 0.000 description 3
235000005911 diet Nutrition 0.000 description 3
210000002249 digestive system Anatomy 0.000 description 3
235000013305 food Nutrition 0.000 description 3
230000007062 hydrolysis Effects 0.000 description 3
238000006460 hydrolysis reaction Methods 0.000 description 3
238000001990 intravenous administration Methods 0.000 description 3
102000004196 processed proteins & peptides Human genes 0.000 description 3
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
206010012735 Diarrhoea Diseases 0.000 description 2
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
238000010521 absorption reaction Methods 0.000 description 2
235000004279 alanine Nutrition 0.000 description 2
210000000170 cell membrane Anatomy 0.000 description 2
230000018044 dehydration Effects 0.000 description 2
238000006297 dehydration reaction Methods 0.000 description 2
238000011161 development Methods 0.000 description 2
230000037213 diet Effects 0.000 description 2
235000014304 histidine Nutrition 0.000 description 2
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
208000015181 infectious disease Diseases 0.000 description 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
239000003182 parenteral nutrition solution Substances 0.000 description 2
235000013930 proline Nutrition 0.000 description 2
238000012546 transfer Methods 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
206010010071 Coma Diseases 0.000 description 1
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
206010019663 Hepatic failure Diseases 0.000 description 1
241000282412 Homo Species 0.000 description 1
206010020852 Hypertonia Diseases 0.000 description 1
102000004877 Insulin Human genes 0.000 description 1
108090001061 Insulin Proteins 0.000 description 1
XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
125000000729 N-terminal amino-acid group Chemical group 0.000 description 1
241000721619 Najas Species 0.000 description 1
102000035195 Peptidases Human genes 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
206010047249 Venous thrombosis Diseases 0.000 description 1
239000002253 acid Substances 0.000 description 1
238000005903 acid hydrolysis reaction Methods 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
208000007502 anemia Diseases 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
235000009697 arginine Nutrition 0.000 description 1
238000013475 authorization Methods 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
230000000747 cardiac effect Effects 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
239000000470 constituent Substances 0.000 description 1
235000018417 cysteine Nutrition 0.000 description 1
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
230000006866 deterioration Effects 0.000 description 1
230000000378 dietary effect Effects 0.000 description 1
239000003814 drug Substances 0.000 description 1
210000001198 duodenum Anatomy 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
230000003203 everyday effect Effects 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
230000012010 growth Effects 0.000 description 1
208000037824 growth disorder Diseases 0.000 description 1
230000009931 harmful effect Effects 0.000 description 1
230000005802 health problem Effects 0.000 description 1
210000003405 ileum Anatomy 0.000 description 1
238000001802 infusion Methods 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
229940125396 insulin Drugs 0.000 description 1
208000028774 intestinal disease Diseases 0.000 description 1
210000004347 intestinal mucosa Anatomy 0.000 description 1
230000003834 intracellular effect Effects 0.000 description 1
210000001630 jejunum Anatomy 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
230000007102 metabolic function Effects 0.000 description 1
229930182817 methionine Natural products 0.000 description 1
210000003205 muscle Anatomy 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
230000035764 nutrition Effects 0.000 description 1
235000006180 nutrition needs Nutrition 0.000 description 1
235000020939 nutritional additive Nutrition 0.000 description 1
235000003715 nutritional status Nutrition 0.000 description 1
229920001542 oligosaccharide Polymers 0.000 description 1
150000002482 oligosaccharides Chemical class 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
238000007911 parenteral administration Methods 0.000 description 1
235000016236 parenteral nutrition Nutrition 0.000 description 1
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
230000002028 premature Effects 0.000 description 1
235000019833 protease Nutrition 0.000 description 1
210000005084 renal tissue Anatomy 0.000 description 1
238000011160 research Methods 0.000 description 1
239000000523 sample Substances 0.000 description 1
235000004400 serine Nutrition 0.000 description 1
230000001954 sterilising effect Effects 0.000 description 1
238000004659 sterilization and disinfection Methods 0.000 description 1
210000002784 stomach Anatomy 0.000 description 1
230000036435 stunted growth Effects 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
235000002374 tyrosine Nutrition 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Mycology (AREA)
Nutrition Science (AREA)
Food Science & Technology (AREA)
Polymers & Plastics (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

BE0/204118A 1980-03-14 1981-03-13 Produits nutritifs et leur procede d'administration. BE887941A (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US13030980A	1980-03-14	1980-03-14

Publications (1)

Publication Number	Publication Date
BE887941A true BE887941A (fr)	1981-07-01

Family

ID=22444078

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BE0/204118A BE887941A (fr)	1980-03-14	1981-03-13	Produits nutritifs et leur procede d'administration.

Country Status (2)

Country	Link
JP (1)	JPS56140923A (de)
BE (1)	BE887941A (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1257806A (en) *	1984-11-19	1989-07-25	Siamak A. Adibi	Nutrient compositions
JPH0764741B2 (ja) *	1985-08-07	1995-07-12	味の素株式会社	栄養組成物
JP2529603B2 (ja) *	1989-10-13	1996-08-28	株式会社大塚製薬工場	分岐鎖アミノ酸製剤
JP5198065B2 (ja) *	2005-09-20	2013-05-15	協和発酵バイオ株式会社	ジペプチド含有経口用組成物

1981
- 1981-03-12 JP JP3595081A patent/JPS56140923A/ja active Granted
- 1981-03-13 BE BE0/204118A patent/BE887941A/fr not_active IP Right Cessation

Also Published As

Publication number	Publication date
JPS56140923A (en)	1981-11-04
JPS6326733B2 (de)	1988-05-31

Legal Events

Date

Code

Title

Description

2001-01-01

RE20

Patent expired

Owner name: MONTEFIORE HOSPITAL ASSOCIATION OF WESTERN PENNSY

Effective date: 20010313

Publication	Publication Date	Title
FR2477843A1 (fr)	1981-09-18	Produits nutritifs et leur procede d'administration
Liddle et al.	1986	Proteins but not amino acids, carbohydrates, or fats stimulate cholecystokinin secretion in the rat
Vinnars et al.	2003	History of parenteral nutrition
Vison et al.	1978	Effect of continuous jejunal perfusion of elemental and complex nutritional solutions on pancreatic enzyme secretion in human subjects.
AU682894B2 (en)	1997-10-23	Composition based on amino acids intended for the treatment of sepsis or of an attack bringing about an inflammatory reaction, in animals and man
McArdle et al.	1986	Prophylaxis Against Radiation Injury: The Use of Elemental Diet Prior to and During Radiotherapy for Invasive Bladder Cancer and in Early Postoperative Feeding Following Radical Cystectomy and Heal Conduit
JPH05502881A (ja)	1993-05-20	免疫刺激剤としてのアルギニンの用途
Lara et al.	1998	Effect of critical illness and nutritional support on mucosalmass and function
US4042688A (en)	1977-08-16	Method of providing high-protein nutrition by the oral administration of a predigested protein composition
US5189016A (en)	1993-02-23	Nutrient compositions containing peptides and method for administering the same
FR2539006A1 (fr)	1984-07-13	Composition rehydratante utilisable notamment dans l'alimentation de jeunes animaux ne pouvant plus digerer normalement le lait et complement pour sa preparation
Twersky et al.	1989	Nutritional deficiencies in chronic pancreatitis
US5122515A (en)	1992-06-16	Nutrient composition containing dipeptides and method for administering the same
EP0655244B2 (de)	2008-06-11	Zusammensetzungen aus Aminosäure zur Behandlung von Infektionen
JP3182564B2 (ja)	2001-07-03	栄養組成物
Perrault et al.	1973	Effects of an elemental diet in healthy volunteers
EP0146474A2 (de)	1985-06-26	Nährlösung enthaltend alpha-Ketoisocapronsäure oder eines ihrer Salze
Silk	1977	Amino acid and peptide absorption in man
JPH07330583A (ja)	1995-12-19	遊離型グルタミン酸を含有する液状製剤
JPS6326733B2 (de)	1988-05-31
Duerksen et al.	2002	A comparison of the effect of elemental and immune‐enhancing polymeric jejunal feeding on exocrine pancreatic function
JPH09110686A (ja)	1997-04-28	マクロファージ一酸化窒素産生亢進剤
Jarnum et al.	1966	Medium chain triglycerides (MCT) in the treatment of protein-losing enteropathy and malabsorption syndromes
KILLIAN et al.	1944	Nutritional problems presented by a patient with extensive jejunoileitis
Meng	1972	Use of fat emulsions in parenteral nutrition